Moderna’s Covid shot is 96% effective in teens ages 12-17 in early trials
Moderna Inc says its COVID-19 vaccine is highly effective among teenagers, early clinical trial data show. In the TeenCOVE study, including children ages 12 to 17, the two-dose shot was 96 percent effective. The results are in line with the 94 percent efficacy Moderna showed among adults in its December 2020 trial that led to … Read more